Loading Map....

Date(s) - 01/23/2020
12:30 pm - 5:30 pm CET

Kursaal Bern


NAMSA is proud to present a half-day seminar dedicated to the learning of the EU’s Medical Device Regulation (MDR), followed by a networking happy hour.

This event, led by regulatory expert, Vincent Legay (NAMSA’s Director of Regulatory Consulting Services-EU), will explore the challenges and implications of MDR compliance from varying perspectives (Sponsors, Notified Bodies, Manufacturers, et. al.) to provide a forum for open discussion, learning and sharing of best practices and effective strategies for conformity.

Focus will be on two key areas where MDR represents the most significant impact for Sponsors:

  • Clinical Evidence for Medical Devices under MDR
    • Is MEDDEV 2.7/1 revision 4 covering all needs?
  • Biocompatibility under MDR
    • Is ISO 10993 sufficient to effectively claim General Safety and Performance Requirements (GSPR) compliance?


Regular Registration: € 150.00 ($165.00 USD)

*** NAMSA reserves the right to cancel 1 week prior to event in the event of low attendance. A full refund will be honored should this occur. ***

Event Details

If making a credit card payment, note that your profile address must match the credit card address on file.

$ 165.00

Please enter your credit card information below


By choosing to submit your information to register for this event, you are providing information to NAMSA that will allow you to receive email alerts to stay informed on industry updates and be directly contacted by NAMSA regarding our services.

At any time, you can submit a request to withdraw your consent for the use of information provided by you by emailing communications@namsa.com. For additional information, please visit our Privacy Policy or contact us at privacy@namsa.com.

NAMSA uses a third-party provider, CyberSource, to process payment when you register for NAMSA's Training Services. For information related to CyberSource's privacy policy and use of that information, please contact CyberSource directly.

12:30 - 13:00 PM Registration
13:00 - 16:30 PM Program
16:30 - 17:30 PM Networking Happy Hour
  Vincent Legay, holds a PhD in Biology and an executive Masters of Business Administration (MBA), and currently serves as NAMSA’s Director Global, Product Development Strategy.  He possesses over 15 years’ experience at NAMSA where he has been responsible for regulatory consulting across the entire medical device lifecycle continuum. This expertise includes management of sterilization, biocompatibility, risk management, clinical evaluation and quality management systems for clients around the globe. Currently, he oversees a cross-functional team of medical device strategists across NAMSA Global entities and also directly supports medical device manufacturers with preclinical and clinical research approaches in an effort to meet regulatory business objectives. vlegay@namsa.com